Cargando…
P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429552/ http://dx.doi.org/10.1097/01.HS9.0000968848.53526.0f |
| _version_ | 1785090743341154304 |
|---|---|
| author | Short, Nicholas Macaron, Walid Dinardo, Courtney Daver, Naval Yilmaz, Musa Borthakur, Gautam Montalban-Bravo, Guillermo Garcia-Manero, Guillermo Issa, Ghayas Sasaki, Koji Burger, Jan Maiti, Abhishek Alvarado, Yesid Thankachan, Jennifer Abramova, Regina Nasr, Lewis Nasnas, Cedric Zoghbi, Marianne Kadia, Tapan Konopleva, Marina Kantarjian, Hagop Ravandi, Farhad |
| author_facet | Short, Nicholas Macaron, Walid Dinardo, Courtney Daver, Naval Yilmaz, Musa Borthakur, Gautam Montalban-Bravo, Guillermo Garcia-Manero, Guillermo Issa, Ghayas Sasaki, Koji Burger, Jan Maiti, Abhishek Alvarado, Yesid Thankachan, Jennifer Abramova, Regina Nasr, Lewis Nasnas, Cedric Zoghbi, Marianne Kadia, Tapan Konopleva, Marina Kantarjian, Hagop Ravandi, Farhad |
| author_sort | Short, Nicholas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429552 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104295522023-08-17 P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY Short, Nicholas Macaron, Walid Dinardo, Courtney Daver, Naval Yilmaz, Musa Borthakur, Gautam Montalban-Bravo, Guillermo Garcia-Manero, Guillermo Issa, Ghayas Sasaki, Koji Burger, Jan Maiti, Abhishek Alvarado, Yesid Thankachan, Jennifer Abramova, Regina Nasr, Lewis Nasnas, Cedric Zoghbi, Marianne Kadia, Tapan Konopleva, Marina Kantarjian, Hagop Ravandi, Farhad Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429552/ http://dx.doi.org/10.1097/01.HS9.0000968848.53526.0f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Short, Nicholas Macaron, Walid Dinardo, Courtney Daver, Naval Yilmaz, Musa Borthakur, Gautam Montalban-Bravo, Guillermo Garcia-Manero, Guillermo Issa, Ghayas Sasaki, Koji Burger, Jan Maiti, Abhishek Alvarado, Yesid Thankachan, Jennifer Abramova, Regina Nasr, Lewis Nasnas, Cedric Zoghbi, Marianne Kadia, Tapan Konopleva, Marina Kantarjian, Hagop Ravandi, Farhad P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title | P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_full | P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_fullStr | P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_full_unstemmed | P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_short | P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_sort | p485: azacitidine, venetoclax and gilteritinib for patients with newly diagnosed flt3-mutated acute myeloid leukemia: a subgroup analysis from a phase ii study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429552/ http://dx.doi.org/10.1097/01.HS9.0000968848.53526.0f |
| work_keys_str_mv | AT shortnicholas p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT macaronwalid p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT dinardocourtney p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT davernaval p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT yilmazmusa p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT borthakurgautam p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT montalbanbravoguillermo p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT garciamaneroguillermo p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT issaghayas p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT sasakikoji p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT burgerjan p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT maitiabhishek p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT alvaradoyesid p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT thankachanjennifer p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT abramovaregina p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT nasrlewis p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT nasnascedric p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT zoghbimarianne p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT kadiatapan p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT konoplevamarina p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT kantarjianhagop p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy AT ravandifarhad p485azacitidinevenetoclaxandgilteritinibforpatientswithnewlydiagnosedflt3mutatedacutemyeloidleukemiaasubgroupanalysisfromaphaseiistudy |